Tumour growth rates of prostate cancer during active surveillance: is there a difference between MRI-visible low and intermediate-risk disease? (2022)
Attributed to:
Defining the microenvironmental contexture of the biopsy-naive, MRI-characterized prostate.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1259/bjr.20210321
PubMed Identifier: 34233491
Publication URI: http://europepmc.org/abstract/MED/34233491
Type: Journal Article/Review
Volume: 95
Parent Publication: The British journal of radiology
Issue: 1131
ISSN: 0007-1285